|
1. CHINA
Collection/compilation agency: Shanghai Science and Technology Commission
Collection/compilation type: Biotechnology experimental survey in Shanghai
Variables: The survey vehicle is in two parts: the first is three tables for quantitative indicators; the second is 8 groups of questions, most of which are non-quantitative.
In survey form:
In survey questionnaire:
-
Status of the associated biotechnological areas
-
Application areas (scope) and products in biotechnologies
-
Human resources
-
Financial resources
-
Intellectual properties
-
Co-operation and exchanges
-
Effect of biotechnological activities
-
Development strategies for biotechnological activities
Scope: Corporations in Shanghai, which are in accord with the statistical definition, include independent research organisations, universities and colleges and companies.
Frequency: Onetime survey carried out in 2004 for reference year 2003.
Periodicity: N/A
Classification used: Biotechnology classification (Shanghai, 2003).
|
1
|
Microorganism engineering
|
|
101
|
Microbial strains; screening, mutation, storage, purification, culture, and various analytical methods concerning varied targeted objects
|
|
102
|
Medium and sterilization
|
|
103
|
Fermentation
|
|
104
|
Parameter detection and analytical technologies
|
|
105
|
Isolation and purification of bioproducts
|
|
106
|
Microbial products
|
|
107
|
Microbial technologies in polar boiling and special environment
|
|
108
|
Others
|
|
2
|
Enzyme engineering
|
|
201
|
Production and preparation of enzyme preparations: fermentation, culture of animal and plant cells, extraction
|
|
202
|
Analysis of enzimatic activity
|
|
203
|
Enzyme mechanism
|
|
204
|
Enzyme reactors: immobilised enzymes; free enzymes
|
|
205
|
Bio-sensors
|
|
206
|
New enzyme preparations
|
|
207
|
Others
|
|
3
|
Cell engineering
|
|
301
|
Culture of plant cells (tube plants)
|
|
302
|
Culture of plant cells
|
|
303
|
Culture of animal cells
|
|
304
|
Animal tissue and organ engineering
|
|
305
|
Cell fusion: asymmetric fusion, cytoplasmic hybrid, protoplast fusion
|
|
306
|
Monoclonal antibody
|
|
307
|
Stem cell
|
|
308
|
Chromosome engineering: polyploid, haploid, gynogenesis, andrigenesis
|
|
309
|
Embryo engineering: artificial insemination, embryonic transplantation, embryonic merogenesis and fusion, sex control, tube animals and infants, breezed embryos, breezed sperm
|
|
310
|
Cell recombination
|
|
311
|
Clone: embryonic cell clone, somatic clone, cloned organ, clonal human being
|
|
312
|
Cell bio-reactor
|
|
313
|
Transgenic cloned animals
|
|
314
|
Transgenic animals: animal milk gland bioreactor, animal blood bioreactor, bio-pharmaceutics
|
|
315
|
Others
|
|
4
|
Gene engineering
|
|
401
|
Transgenic technologies: transformation, transduction, transfection
|
|
402
|
Genes' duplication, transcription, and translation
|
|
403
|
DNA isolation
|
|
404
|
DNA amplification: clone, PCR technologies
|
|
405
|
Site-directed mutagenesis
|
|
406
|
Plasmid vector
|
|
407
|
Tool enzyme
|
|
408
|
Receptor cell
|
|
409
|
Screening technology
|
|
410
|
Expression and regulation of inductions
|
|
411
|
Occlusion body
|
|
412
|
Detection and analysis of targeted yields
|
|
413
|
Detection and analysis of targeted DNA
|
|
414
|
Gene rearrangement technology
|
|
415
|
Knock-out technology
|
|
416
|
Gene modifications
|
|
417
|
Gene therapy
|
|
418
|
Gene finger technology
|
|
419
|
DNA sequencing and sequence analysis; DNA sequencing/synthesis/amplification
|
|
420
|
Bioinformatics
|
|
421
|
Bio-analysis software packages
|
|
422
|
Bioinformation (data) library
|
|
423
|
Gene chips
|
|
424
|
Functional genomics
|
|
425
|
Structural genomics
|
|
426
|
Transgenic food
|
|
427
|
Transgenic animals
|
|
428
|
Transgenic plants
|
|
429
|
Transgenic microbial
|
|
430
|
Others
|
|
5
|
Biochemical engineering
|
|
501
|
Automatic control
|
|
502
|
Online parameter detection and analysis
|
|
503
|
Dynamics of bio-reactions
|
|
504
|
Bio-reactors
|
|
505
|
Amplified processes of bio-reactions
|
|
506
|
Biological products
|
|
507
|
Cytoclasis
|
|
508
|
Salting out
|
|
509
|
Extraction
|
|
510
|
Precipitation
|
|
511
|
Chromatography
|
|
512
|
Others
|
|
6
|
Protein engineering
|
|
601
|
Expression system
|
|
602
|
Isolation and purification of proteins
|
|
603
|
Fusion protein
|
|
604
|
Protein folding
|
|
605
|
Protein modification
|
|
606
|
Gene modification
|
|
607
|
Structure prediction
|
|
608
|
Protein product
|
|
609
|
Others
|
|
7
|
Metabolism engineering
|
|
701
|
Metabolism regulation
|
|
702
|
Metabolism network
|
|
703
|
Induction and blockade
|
|
704
|
Flow of metabolites
|
|
705
|
Others
|
|
8
|
Miscellaneous (mainly including biomedicine engineering, biomaterials, etc.)
|
|
801
|
Environmental-friendly bio-materials
|
|
802
|
Degradable biomaterials
|
|
803
|
Bio-medical materials
|
|
804
|
Bio-functional materials
|
|
805
|
Bio-thermodynamics
|
|
806
|
Biophysics
|
|
807
|
Others
|
Definition used: Biotechnology is an activity to modify living organisms or processing biological material according to beforehand design, which is based on modern life science, and combined with advanced engineering technology and other basic science theory, to provide products or services.
Output: Shanghai Biotechnology Survey Report 2003, planned to be released in September 2004.
Contact comments: This was a regional experimental survey in Shanghai, China.
Future plans: Future plans will depend on the analysis of the results of the survey.
Contact details: www.stcsm.gov.cn
2. CHINA
This survey is in two parts
Collection/compilation agency: Ministry of Science and Technology
Collection/compilation type: Biotechnology Industry Park Survey
Variables:
-
General information: development plan, supported policy, problem and advice during Biotechnology Industry Park development
-
Park information: name, certified time, type, planned area, exploited area, output value, pre-tax profit, investment
-
S&T activity: number of S&T project, R&D expenditure, R&D expenditure as a percentage of total expenditure for the Park, R&D personnel, R&D personnel as a percentage of total employees for the Park, patents received and patents granted since the Park established
-
Operating information: company number in the Park, company employee, outpout value, pre-tax profit, investment by source of funds
Scope: National
Frequency: 2003
Periodicity: Onetime survey
Definition: No definition is provided in the survey
Output: Only available in Chinese and without publication
Contact details: N/A
-------------------------------------------------------------------------------------------------------------------------------------------
Collection/compilation agency: Ministry of Science and Technology
Collection/compilation type: Biotechnology Company Survey
Variables:
-
Company information: company name, founder background, type of registration, located park name, time of enter park, registered capital, fixed assets, output value per year, enterprise tax, total expenditure, type of major activity, type of major product
-
Employees: total, employee structure by work and by education level
-
Patent: useful time, country covered, application fee, holding fee, R&D expenditure
-
Major product: sales revenue, profits, technology level of product, technology level of productive equipment, resource of core technology, market shares in domestic and abroad, belonging to which national S&T programme
-
R&D activity: R&D personnel, intramural R&D expenditure, extramural R&D expenditure
Scope: Companies in Biotechnology Industry Park
Frequency: 2003
Periodicity: Onetime survey
Definition: No definition is provided in the survey
Output: Only available in Chinese and without publication
Contact details: NA
|
